A case of malignant insulinoma responsive to somatostatin analogs treatment

A case of malignant insulinoma responsive to somatostatin analogs treatment

Abstract Background Insulinoma is a rare tumour representing 1–2% of all pancreatic neoplasms and it is malignant in only 10% of cases. Locoregional invasion or metastases define malignancy, whereas the dimension (> 2 cm), CK19 status, the tumor staging and grading (Ki67 > 2%), and the age of...

Full description

Bibliographic Details
Main Authors: Mariasmeralda Caliri, Valentina Verdiani, Edoardo Mannucci, Vittorio Briganti, Luca Landoni, Alessandro Esposito, Giulia Burato, Carlo Maria Rotella, Massimo Mannelli, Alessandro Peri
Format: Article
Language:English
Published: BMC 2018-12-01
Series:BMC Endocrine Disorders
Subjects:
Insulinoma
Hypoglycemia
Somatostatin analogs
Octreotide
Online Access:http://link.springer.com/article/10.1186/s12902-018-0325-4

Internet

http://link.springer.com/article/10.1186/s12902-018-0325-4

Similar Items